NPCE supply chain intelligence for NeuroPace, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
NeuroPace, Inc. (NPCE) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ITGR | Integer Holdings Corporation | 92% | ment AG and Integer Holdings Corporation (formally known as Greatbatch Ltd) are single-source suppliers of several key components of our products, including printed circuit assemblies and batteries. … |
| ITGR | Integer Holdings Corporation | 92% | Reciprocal relationship from ITGR graph: Reciprocal relationship from NPCE graph: ment AG and Integer Holdings Corporation (formally known as Greatbatch Ltd) are single-source suppliers of several ke… |
| MICRO-SYSTEMS-TECHNOLOGIES-MANAGEMENT-AG | MICRO-SYSTEMS-TECHNOLOGIES-MANAGEMENT-AG | 92% | For example, Micro Systems Technologies Management AG and Integer Holdings Corporation (formally known as Greatbatch Ltd) are single-source suppliers of several key components of our products, includ… |
| LIVN | LivaNova PLC | 72% | rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatment of these patients. Our primary competit… |
| LIVN | LivaNova PLC | 72% | Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE graph: rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from NPCE graph: rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of … |
| MDT | Medtronic plc | 72% | rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatment of these patients. Our primary competit… |
| RAPP | Rapport Therapeutics, Inc. | 72% | Reciprocal relationship from RAPP graph: Reciprocal relationship from NPCE graph: ody of peer-reviewed publications and scientific research involving our RNS System. We also engage in direct-to-patie… |
| RAPP | Rapport Therapeutics, Inc. | 72% | ody of peer-reviewed publications and scientific research involving our RNS System. We also engage in direct-to-patient marketing activities including targeted online advertising and social media to … |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| ITGR | Integer Holdings Corporation | 72% | ment AG and Integer Holdings Corporation (formally known as Greatbatch Ltd) are single-source suppliers of several key components of our products, including printed circuit assemblies and batteries. … |
| ITGR | Integer Holdings Corporation | 72% | Reciprocal relationship from ITGR graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from ITGR graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from ITGR g… |
| LIVN | LivaNova PLC | 72% | Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from LIVN g… |
| LIVN | LivaNova PLC | 72% | rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatment of these patients. Our primary competit… |
| MDT | Medtronic plc | 72% | rgery or are unwilling to undergo a destructive surgical procedure and we compete primarily with two manufacturers of neuromodulation devices for the treatment of these patients. Our primary competit… |
| MDT | Medtronic plc | 72% | Reciprocal relationship from MDT graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from MDT graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from MDT grap… |
| RAPP | Rapport Therapeutics, Inc. | 72% | ody of peer-reviewed publications and scientific research involving our RNS System. We also engage in direct-to-patient marketing activities including targeted online advertising and social media to … |
| RAPP | Rapport Therapeutics, Inc. | 72% | Reciprocal relationship from RAPP graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from RAPP graph: Reciprocal relationship from NPCE graph: Reciprocal relationship from RAPP g… |
| DIXI-MEDICAL-USA-CORP | DIXI-MEDICAL-USA-CORP | 62% | as of March 31, 2026 and December 31, 2025, respectively. 4. Balance Sheet Components Inventory Inventories consist of the following: March 31, December 31, (in thousands) 2026 2025 Raw materials $ 6… |
| INTEGER-HOLDINGS | INTEGER-HOLDINGS | 62% | ion of, a supplier’s operations; • delays in product shipments resulting from uncorrected defects, reliability issues or a supplier’s failure to produce components that consistently meet our quality … |
| KCK-LTD | KCK-LTD | 62% | elopment employees, including stock-based compensation, and expenses related to consulting services, clinical trials, regulatory activities, prototyping, testing, materials and supplies, and allocate… |
| LEERINK-PARTNERS-LLC | LEERINK-PARTNERS-LLC | 62% | elopment employees, including stock-based compensation, and expenses related to consulting services, clinical trials, regulatory activities, prototyping, testing, materials and supplies, and allocate… |
| MICRO-SYSTEMS-TECHNOLOGIES-MANAGEMENT-AG | MICRO-SYSTEMS-TECHNOLOGIES-MANAGEMENT-AG | 62% | n delivery by our suppliers of components, materials, or services due to changes in demand from us or their other customers. The occurrence of any of these issues could significantly harm our ability… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| NPCE-DEBT-11347 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2021-12-31. |
| NPCE-DEBT | Debt stack $59.0M | 90% | Market cache reports total debt of $59.0M. |
| NPCE-DEBT-11346 | Warrants outstanding: 0 | 90% | xbrl warrant detail from xbrl 2022-12-31. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| NPCE-OWNER-MORGAN-STANLEY | MORGAN STANLEY | 90% | 13F overlay lists MORGAN STANLEY as top holder; 112 tracked holders. |
| Ticker | Name | Chain Index | Hops | Relationship Types |
|---|---|---|---|---|
| SSII | SS Innovations International, Inc. | 100.00 | 2 | |
| XTNT | Xtant Medical Holdings, Inc. | 100.00 | 2 | |
| ITGR | Integer Holdings Corporation | 100.00 | 1 | ['customer', 'supplier'] |
| ISRG | Intuitive Surgical, Inc. | 100.00 | 2 | |
| TELA | TELA Bio, Inc. | 100.00 | 2 | |
| PYPD | PolyPid Ltd. | 100.00 | 2 | |
| LIVN | LivaNova PLC | 100.00 | 1 | ['customer', 'supplier'] |
| NDRA | ENDRA Life Sciences Inc. | 100.00 | 2 | |
| RAPP | Rapport Therapeutics, Inc. | 100.00 | 1 | ['customer', 'supplier'] |
| IART | Integra LifeSciences Holdings Corporation | 100.00 | 2 | |
| ABT | Abbott Laboratories | 100.00 | 2 | |
| GWW | W.W. Grainger, Inc. | 100.00 | 2 | |
| OBIO | Orchestra BioMed Holdings, Inc. | 100.00 | 2 | |
| MDT | Medtronic plc | 100.00 | 1 | ['customer', 'supplier'] |
| PLSE | Pulse Biosciences, Inc. | 100.00 | 2 | |
| NYXH | Nyxoah SA | 100.00 | 2 | |
| OM | Outset Medical, Inc. | 50.00 | 2 | |
| PODD | Insulet Corporation | 50.00 | 2 | |
| XENE | Xenon Pharmaceuticals Inc. | 50.00 | 2 | |
| AVR | Anteris Technologies Global Corp. | 50.00 | 2 |